The UK government and the European Union Drugs Agency (EUDA) have signed a working agreement to help identify dangerous substances earlier.
New psychoactive substances are being detected in Europe at a rate of around one a week, with more than 1,000 currently being monitored – including highly potent synthetic opioids.
The new arrangement will help reduce harm by supporting reciprocal exchanges of information on newly detected substances, emerging threats, and high-risk drugs in circulation, says EUDA. It was signed by public health minister Sharon Hodgson and EUDA director Dr Lorraine Nolan, with UK implementation to be jointly led by DHSC and the Home Office.
‘This working arrangement marks an important new chapter in the relationship between the European Union Drugs Agency and the United Kingdom,’ said Nolan. ‘As drug markets evolve rapidly and become increasingly interconnected, closer cooperation is essential. This agreement provides a practical framework for sharing data, expertise and research, strengthening early warning and improving our understanding of emerging threats. By working together, we will be better equipped to respond to drug-related challenges and to help safeguard public health and security.’
Meanwhile, DHSC has launched a consultation on plans to stop vapes being marketed to children, including keeping them out of sight in shops, plain white packaging and restrictions on flavour names. ‘Vapes are less harmful than cigarettes and can play an important role in helping adult smokers to quit, but they should never be designed or marketed in ways that tempt children,’ said health secretary James Murray. ‘These proposals are about striking the right balance and I urge everyone to have their say.’
Working arrangement document available here
Tobacco and vapes: packaging, appearance and display open consultation available here until 2 October